TY - JOUR
T1 - GABAA receptor signalling mechanisms revealed by structural pharmacology
AU - Masiulis, Simonas
AU - Desai, Rooma
AU - Uchański, Tomasz
AU - Serna Martin, Itziar
AU - Laverty, Duncan
AU - Karia, Dimple
AU - Malinauskas, Tomas
AU - Zivanov, Jasenko
AU - Pardon, Els
AU - Kotecha, Abhay
AU - Steyaert, Jan
AU - Miller, Keith W.
AU - Aricescu, A. Radu
N1 - Publisher Copyright:
© 2019, Springer Nature Limited.
PY - 2019/1/24
Y1 - 2019/1/24
N2 - Type-A γ-aminobutyric (GABAA) receptors are ligand-gated chloride channels with a very rich pharmacology. Some of their modulators, including benzodiazepines and general anaesthetics, are among the most successful drugs in clinical use and are common substances of abuse. Without reliable structural data, the mechanistic basis for the pharmacological modulation of GABAA receptors remains largely unknown. Here we report several high-resolution cryo-electron microscopy structures in which the full-length human α1β3γ2L GABAA receptor in lipid nanodiscs is bound to the channel-blocker picrotoxin, the competitive antagonist bicuculline, the agonist GABA (γ-aminobutyric acid), and the classical benzodiazepines alprazolam and diazepam. We describe the binding modes and mechanistic effects of these ligands, the closed and desensitized states of the GABAA receptor gating cycle, and the basis for allosteric coupling between the extracellular, agonist-binding region and the transmembrane, pore-forming region. This work provides a structural framework in which to integrate previous physiology and pharmacology research and a rational basis for the development of GABAA receptor modulators.
AB - Type-A γ-aminobutyric (GABAA) receptors are ligand-gated chloride channels with a very rich pharmacology. Some of their modulators, including benzodiazepines and general anaesthetics, are among the most successful drugs in clinical use and are common substances of abuse. Without reliable structural data, the mechanistic basis for the pharmacological modulation of GABAA receptors remains largely unknown. Here we report several high-resolution cryo-electron microscopy structures in which the full-length human α1β3γ2L GABAA receptor in lipid nanodiscs is bound to the channel-blocker picrotoxin, the competitive antagonist bicuculline, the agonist GABA (γ-aminobutyric acid), and the classical benzodiazepines alprazolam and diazepam. We describe the binding modes and mechanistic effects of these ligands, the closed and desensitized states of the GABAA receptor gating cycle, and the basis for allosteric coupling between the extracellular, agonist-binding region and the transmembrane, pore-forming region. This work provides a structural framework in which to integrate previous physiology and pharmacology research and a rational basis for the development of GABAA receptor modulators.
UR - http://www.scopus.com/inward/record.url?scp=85060365964&partnerID=8YFLogxK
U2 - 10.1038/s41586-018-0832-5
DO - 10.1038/s41586-018-0832-5
M3 - Article
C2 - 30602790
AN - SCOPUS:85060365964
SN - 0028-0836
VL - 565
SP - 454
EP - 459
JO - Nature
JF - Nature
IS - 7740
ER -